☆ 4.7 Letter

Methylprednisolone added to tocilizumab reduces mortality in SARS-CoV-2 pneumonia: An observational study

JOURNAL OF INTERNAL MEDICINE (2021)

Journal

JOURNAL OF INTERNAL MEDICINE

Volume 289, Issue 2, Pages 259-263

Publisher

WILEY

DOI: 10.1111/joim.13145

Keywords

COVID-19; methylprednisolone; SARS-CoV-2; survival; tocilizumab

Categories

Medicine, General & Internal

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.